{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:37:12Z","timestamp":1783676232863,"version":"3.55.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1212\/01.con.0000461086.79241.3b","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T06:28:14Z","timestamp":1423117694000},"page":"84-99","source":"Crossref","is-referenced-by-count":15,"title":["Metabolic and Toxic Causes of Myelopathy"],"prefix":"10.1212","volume":"21","author":[{"given":"Brent P.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Allen LH. How common is vitamin B-12 deficiency. Am J Clin Nutr 2009; 89 (2): 6935\u20136965. doi:10.3945\/ajcn.2008.26947A.","DOI":"10.3945\/ajcn.2008.26947A"},{"key":"e_1_3_1_3_2","unstructured":"National Institutes of Health. Office of Dietary Supplements. Vitamin B12 Dietary Supplement Fact Sheet. National Institutes of Health Office of Dietary Supplements website. ods.od.nih.gov\/factsheets\/VitaminB12-HealthProfessional\/. Reviewed June 24 2011. Accessed December 5 2014."},{"key":"e_1_3_1_4_2","doi-asserted-by":"crossref","unstructured":"Dali-Youcef N Andr\u00e8s E. An update on cobalamin deficiency in adults. QJM 2009; 102 (1): 17\u201328. doi:10.1093\/qjmed\/hcn138.","DOI":"10.1093\/qjmed\/hcn138"},{"key":"e_1_3_1_5_2","doi-asserted-by":"crossref","unstructured":"Russell JSR Batten FE Collier J. Subacute combined degeneration of the spinal cord. Brain 1900; 23 (1): 39\u2013110. doi:10.1093\/brain\/23.1.39.","DOI":"10.1093\/brain\/23.1.39"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","unstructured":"Valente E Scot JM Ueland P et al. Diagnostic accuracy of holotranscobalamin methylmalonic acid serum cobalamin and other indicators of tissue vitamin B12 status in the elderly. Clin Chem 2011; 57 (6): 856\u2013863. doi:10.1373\/clinchem.2010.158154.","DOI":"10.1373\/clinchem.2010.158154"},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Remacha AF Sard\u00e0 MP Canals C et al. Role of serum holotranscobalamin (holoTC) in the diagnosis of patients with low serum cobalamin. Comparison with methylmalonic acid and homocysteine. Ann Hematol 2014; 93 (4): 565\u2013569. doi:10.1007\/s00277-013-1905-z.","DOI":"10.1007\/s00277-013-1905-z"},{"key":"e_1_3_1_10_2","doi-asserted-by":"crossref","unstructured":"Kumar A Sing AK. Teaching neuroimage: inverted V sign in subacute combined degeneration of spinal cord. Neurology 2009; 72 (1): e4. doi:10.1212\/01.wnl.0000338663.59433.9c.","DOI":"10.1212\/01.wnl.0000338663.59433.9c"},{"key":"e_1_3_1_11_2","doi-asserted-by":"crossref","unstructured":"Puntambekar P Basha MM Zak IT Madhavan R. Rare sensory and autonomic disturbances associated with vitamin B12 deficiency. J Neurol Sci 2009; 287 (1\u20132): 285\u2013287. doi:10.106\/j.jns.2009.07.030.","DOI":"10.1016\/j.jns.2009.07.030"},{"key":"e_1_3_1_12_2","doi-asserted-by":"crossref","unstructured":"Pandey S Kalita J Misra UK. A sequential study of visual evoked potential in patients with vitamin B12 deficiency neurological syndrome. Clin Neurophysiol 2004; 115 (4): 914\u2013918. doi:10.1016\/j.clinph.2003.11.013.","DOI":"10.1016\/j.clinph.2003.11.013"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","unstructured":"Vidal-Alaball J Butler CC Cannings-John R et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005; (3): CD004655. doi:10.1002\/14651858.CD004655.pub2.","DOI":"10.1002\/14651858.CD004655.pub2"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Butler CC Vidal-Alaball J Cannings-John R et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency: a systematic review of randomized controlled trials. Fam Pract 2006; 23 (3): 279\u2013285. doi:10.1093\/fampra\/cml008.","DOI":"10.1093\/fampra\/cml008"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Okada A Koike H Nakamura T et al. Slowly progressive folate deficiency-myelopathy: report of a case. J Neurol Sci 2014; 336 (1\u20132): 273\u2013275. doi:10.1016.","DOI":"10.1016\/j.jns.2013.10.032"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Kumar N. Neurologic presentations of nutritional deficiencies. Neurol Clin 2010; 28 (1): 107\u2013170. doi:10.1016\/j.ncl.2009.09.006.","DOI":"10.1016\/j.ncl.2009.09.006"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","unstructured":"Lanska DJ Remler B. Myelopathy among zinc-smelter workers in Upper Silesia during the late 19th century. Neurology 2014; 82 (13): 1175\u20131179. doi:10.1212\/WNL.0000000000000270.","DOI":"10.1212\/WNL.0000000000000270"},{"key":"e_1_3_1_18_2","doi-asserted-by":"crossref","unstructured":"Zittel S Ufer F Gerloff C et al. Severe myelopathy after denture cream use\u2014is copper deficiency or excess zinc the cause? Clin Neurol Neurosurg 2014; 121: 17\u201318. doi:10.1016\/j.clineuro.2014.03.013.","DOI":"10.1016\/j.clineuro.2014.03.013"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","unstructured":"McCreary M Emerman C Hanna J Simon J. Acute myelopathy following intranasal insufflation of heroin: a case report. Neurology 2000; 55 (2): 316\u2013317. doi:10.1212\/WNL.55.2.316-a.","DOI":"10.1212\/WNL.55.2.316-a"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","unstructured":"Riva N Morana P Cerri F et al. Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin. J Neurol Neurosurg Psychiatry 2007; 78 (8): 908\u2013909. doi:10.1136\/bcr.08.2008.0669.","DOI":"10.1136\/jnnp.2006.109207"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","unstructured":"Nzwalo H Cliff J. Konzo: from poverty cassava and cyanogen intake to toxico-nutritional neurological disease. PLoS Negl Trop Dis 2011; 5 (6): e1051. doi:10.1371\/journal.pntd.0001051.","DOI":"10.1371\/journal.pntd.0001051"},{"key":"e_1_3_1_24_2","doi-asserted-by":"crossref","unstructured":"Banea JP Nahimana G Mandombi C et al. Control of konzo in DRC using the wetting method on cassava flour. Food Chem Toxicol 2012; 50 (5): 1517\u20131523. doi:10.1016\/j.fct.2012.001.","DOI":"10.1016\/j.fct.2012.02.001"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Tshala-Katumbay D Mumba N Okitundu L et al. Cassava food toxins konzo disease and neurodegeneration in sub-Sahara Africans. Neurology 2013; 80 (10): 949\u2013951. doi:10.1212\/WNL.0b013e3182840b81.","DOI":"10.1212\/WNL.0b013e3182840b81"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","unstructured":"Barceloux DG. Medical toxicology of natural substances: foods fungi medicinal herbs plants and venomous animals. Hoboken NJ: John Wiley & Sons 2008: 62\u201366.","DOI":"10.1002\/9780470330319"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Mishra VN Tripathi CB Kumar A et al. Lathyrism: has the scenario changed in 2013? Neurol Res 2014; 36 (1): 38\u201340. doi:10.1179\/1743132813Y.0000000258.","DOI":"10.1179\/1743132813Y.0000000258"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Woldeamanuel YW Hassan A Zenebe G. Neurolathyrism: two Ethiopian case reports and review of the literature. J Neurol 2012; 259 (7): 1263\u20131268. doi:10.1007\/s00415-011-6306-4.","DOI":"10.1007\/s00415-011-6306-4"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","unstructured":"Striefler M Cohn DF Hirano A Schujman E. The central nervous system in a case of neurolathyrism. Neurology 1977; 27 (12): 1176\u20131178. doi:10.1212\/WNL.27.12.1176.","DOI":"10.1212\/WNL.27.12.1176"},{"key":"e_1_3_1_30_2","doi-asserted-by":"crossref","unstructured":"Chamberlain M Eaton KD Fink J. Radiation-induced myelopathy: treatment with bevacizumab. Arch Neurol 2011; 68 (12): 1608\u20131609. doi:10.1001\/archneurol.2011.621.","DOI":"10.1001\/archneurol.2011.621"},{"key":"e_1_3_1_31_2","doi-asserted-by":"crossref","unstructured":"Schaumburg H Herskovitz S. Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy? Neurology 2008; 71 (9): 622\u2013623. doi:10.1212\/01.wnl.0000324620.86645.c1.","DOI":"10.1212\/01.wnl.0000324620.86645.c1"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Kimura E Hirano T Yamashita et al. Cervical MRI of subacute myelo-optico-neuropathy. Spinal Cord 2011; 49 (2): 182\u2013185. doi:10.1038\/sc.2010.68.","DOI":"10.1038\/sc.2010.68"},{"key":"e_1_3_1_33_2","doi-asserted-by":"crossref","unstructured":"Schwendimann RN. Metabolic nutritional and toxic myelopathies. Neurol Clin 2013; 31 (1): 207\u2013218. doi:10.1016\/j.ncl.2012.09.002.","DOI":"10.1016\/j.ncl.2012.09.002"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/01.CON.0000461086.79241.3b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:12:05Z","timestamp":1752156725000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/01.CON.0000461086.79241.3b"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1212\/01.CON.0000461086.79241.3b"],"URL":"https:\/\/doi.org\/10.1212\/01.con.0000461086.79241.3b","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}